Eyemaxx Real Estate AG

  • WKN: A0V9L9
  • ISIN: DE000A0V9L94
  • Land: Deutschland

Nachricht vom 10.10.2019 | 13:45

Eyemaxx sells stake in ViennaEstate

DGAP-News: Eyemaxx Real Estate AG / Key word(s): Investment/Disposal

10.10.2019 / 13:45
The issuer is solely responsible for the content of this announcement.


Eyemaxx sells stake in ViennaEstate

Aschaffenburg, 10 October 2019 - Eyemaxx Real Estate AG (General Standard; ISIN: DE000A0V9L94; "Eyemaxx") has completely sold its 26% stake in ViennaEstate Immobilien AG ("ViennaEstate"). The buyer is a renowned Austrian real estate investor. As a result of the sale, net earnings in a high single digit million euro range accrue to the company. The purchase price will be paid in two tranches - the first in December 2019, the second at the beginning of 2020.

The strategic partnership between Eyemaxx and ViennaEstate remains unchanged. This means that Eyemaxx continues to be the preferred planning and development service provider of ViennaEstate for B2C developer projects in Austria and Germany. In this region ViennaEstate intends to build up to 1,000 residential units within the framework of developer projects.

Dr. Michael Müller, CEO of Eyemaxx Real Estate AG: "We will use the inflow of funds from the divestiture for the support of our corporate growth and for new projects. I am personally very optimistic as far as the further business development of Eyemaxx is concerned."
 

About Eyemaxx Real Estate AG

Eyemaxx Real Estate AG is a real estate company with a long-standing successful track record, focussing on residential properties in Germany and Austria. In the company's recent past its corporate strategy has also included hotels and serviced apartments as well as developing urban districts in Germany.

Eyemaxx' business activities take a dual-pronged approach. These include high-margin projects and also the continued expansion of its stocks of let commercial properties, which generate ongoing rental income and thus constant cash flows. In so doing, Eyemaxx uses the expertise offered by its experienced management team together with a strong team of real estate professionals, and also a well-established and broad network which opens up additional access to attractive properties and projects. As a result, the current project pipeline has been grown to a total of around EUR 855 million.

Shares of Eyemaxx Real Estate AG are listed in the General Standard of the Frankfurt Stock Exchange and in the direct market plus on the Vienna Stock Exchange. The company has also issued several bonds, which are likewise listed on the stock exchange.

You can find more information at www.eyemaxx.com

 

Contact

Investor Relations / Financial Press
Axel Mühlhaus, Peggy Kropmanns
edicto GmbH
Telephone: +49 69 905505-52
Email: eyemaxx@edicto.de



10.10.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Anleihe im Fokus

Deutsche Rohstoff
"Anleihe - Jetzt zeichnen!"

- Emissionsvolumen: bis zu 100 Mio. EUR
- Zeichnungsfrist: 11.11. bis 04.12.2019
- ISIN: DE000A2YN3Q8 / WKN: A2YN3Q
- Börsenesegment: Börse Frankfurt, Open Market (Quotation Board)
- Stückelung / Emissionspreis: 1.000 EUR/ 100%
- Zinssatz (Kupon): 5,25 %
- Laufzeit: 5 Jahre
- Fälligkeit: 5 Jahre / 6.12.2024 (vorbehaltliche vorzeitige Rückzahlung gemäß Anleihebedingungen)
- Zinszahlung: Angebot an Inhaber der 5,625 % Schuldverschreibung 2016/2021 (WKN A2AA05, ISIN DE000A2AA055) diese in die neue Anleihe zu tauschen
- Umtauschfrist: 11.11.2019 – 29.11.2019 (18.00 Uhr)

GBC-Fokusbox

Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

Aktueller Webcast

EQS Group AG

Conference Call zu den Neunmonatszahlen 2019

15. November 2019

Aktuelle Research-Studie

Media and Games Invest plc

Original-Research: Media and Games Invest plc (von GBC AG): Kaufen

18. November 2019